December 18, 2012 at 10:17 AM EST
WuXi PharmaTech Teams Up with PRA to Form Clinical JV
WuXi PharmaTech, a CRO known mostly for its pre-clinical services is forming a JV with PRA, a US-based clinical-stage CRO. The JV will offer Phase I-IV clinical trial management and related services in China, Hong Kong and Macau. WuXi entered the clinical sphere in a small way one year ago by buying MedKey Med-Tech Development, a CRO located in China. But the company seems to have wanted a bigger presence on the clinical side, a presence that would be closer to its eminent stature in the pre-clinical market More details.... Stock Symbol: (NYSE: WX) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here